Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jounce Therapeutics Inc.

    NASDAQ: JNCE · Real-Time Price · USD
    1.88
    0.00 (0.00%)
    At close: May 03, 2023, 10:00 PM

    Jounce Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 82M 26.91M
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 82M 26.91M
    Operating Income
    		 -52.24M -91.06M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -50.78M -90.86M
    Net Income
    		 -50.92M -90.87M
    Selling & General & Admin
    		 30.97M 28.98M
    Research & Development
    		 103.27M 88.98M
    Other Expenses
    		 n/a 199K
    Operating Expenses
    		 134.24M 117.96M
    Interest Expense
    		 n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 134.24M 117.96M
    Income Tax Expense
    		 135K 15K
    Shares Outstanding (Basic)
    		 51.68M 49.93M
    Shares Outstanding (Diluted)
    		 51.68M 49.93M
    EPS (Basic)
    		 -0.99 -1.82
    EPS (Diluted)
    		 -0.99 -1.82
    EBITDA
    		 -50.16M -91.06M
    EBIT
    		 -52.24M n/a
    Depreciation & Amortization
    		 2.09M 2.83M

    Add to Watchlist